Riset dan Pengabdian Masyarakat
Do Research Sosial Service and Innovation
Publikasi Scopus 2024 per tanggal 31 Juli 2024 (607 artikel)
Publikasi Scopus 2024 per tanggal 31 Juli 2024 (607 artikel)
Danpanichkul, Pojsakorn (57963658100); Uawithya, Ekdanai (58906254500); Lopimpisuth, Chawin (57212483647); Sukphutanan, Banthoon (58532932000); Kulthamrongsri, Narathorn (57468252000); Aboona, Majd B. (57751393600); Duangsonk, Kwanjit (6507430994); Lau, Sirimas (59205599900); Simadibrata, Daniel M. (57202134322); Daggag, Hinda (24757982600); Wallace, Michael B. (7401942875); Wijarnpreecha, Karn (56324138000)
Early-onset pancreatic cancer and associated metabolic risk factors in the Middle East and North Africa: A 20-year analysis of the Global Burden of Disease Study
2024
Indian Journal of Gastroenterology
0
https://www.scopus.com/inward/record.uri?eid=2-s2.0-85197649354&doi=10.1007%2fs12664-024-01626-x&partnerID=40&md5=9ec9e5b63ea902200745eb45f1938637
Department of Internal Medicine, Texas Tech University Health Sciences Center, Lubbock, TX, United States; Immunology Unit, Department of Microbiology, Faculty of Medicine, Chiang Mai University, Chiang Mai, Thailand; Faculty of Medicine Siriraj Hospital, Mahidol University, Nakhon Pathom, Thailand; Department of Internal Medicine, University of Miami, Jackson Memorial Hospital, Miami, FL, United States; Faculty of Medicine, Chiang Mai University, Chiang Mai, Thailand; Department of Pharmacology, Faculty of Medicine Siriraj Hospital, Mahidol University, Nakhon Pathom, Thailand; Department of Cardiovascular Medicine, Mayo Clinic Arizona, Phoenix, AZ, United States; Department of Internal Medicine, University of Arizona College of Medicine, Phoenix, AZ, United States; Department of Microbiology, Faculty of Medicine, Chiang Mai University, Chiang Mai, Thailand; Department of Internal Medicine, Metrowest Medical Center, Framingham, MA, United States; Faculty of Medicine, Universitas Indonesia, Jakarta, Indonesia; Division of Gastroenterology and Hepatology, Mayo Clinic, Rochester, MN, United States; Imperial College London Diabetes Centre, Abu Dhabi, United Arab Emirates; Division of Gastroenterology and Hepatology, Mayo Clinic, Jacksonville, FL, United States; Department of Gastroenterology, Sheikh Shakhbout Medical City, Abu Dhabi, United Arab Emirates; Division of Gastroenterology and Hepatology, Department of Medicine, University of Arizona College of Medicine, Phoenix, AZ, United States; Division of Gastroenterology and Hepatology, Department of Internal Medicine, Banner University Medical Center, Phoenix, AZ, United States; BIO5 Institute, University of Arizona College of Medicine-Phoenix, Phoenix, AZ, United States
Background and Objective: Early-onset pancreatic cancer (EOPC) is associated with poor prognosis and high disease burden. Metabolic risk factors such as diabetes and obesity are considered risk factors of EOPC. Recently, there has been an increasing number of EOPCs worldwide. However, the analysis of EOPC, including its metabolic risk factors, in the Middle East and North Africa (MENA) region has not been fully addressed. Methods: Data from the Global Burden of Disease Study between 2000 and 2019 was used to analyze the prevalence, incidence, deaths and disability-adjusted life years (DALYs) associated with EOPC and its metabolic risk factors. The analysis further categorized the data based on countries, income status and sex and examined the annual percentage change (APC). Results: Approximately 2800 cases, 2400 deaths and 114,000 DALYs were attributable to EOPC in the MENA region. The incidence (APC + 3.42%), death (APC + 0.73%) and DALYs (APC + 3.23%) rates of EOPC increased. In addition, the death and DALY rates of EOPC attributable to obesity and diabetes increased. High and upper-middle-income countries exhibited a higher burden of EOPC than lower-income countries. Conclusion: Over the past two decades, the burden of EOPC and its associated metabolic risk factors has increased. There is an urgent need for region-wide policy development, including screening methods and risk factor reduction, to mitigate the high and rising burden of EOPC in the MENA region. Graphical Abstract: (Figure presented.). © Indian Society of Gastroenterology 2024.
Virgo Inc
Michael B. Wallace: consulting: Cosmo/Aries Pharmaceuticals, Verily, Boston Scientific, Endiatx, InterVenn, AlphaMed UAE, Fujifilm; research grants: Fujifilm, Boston Scientific, Olympus, Medtronic, Ninepoint Medical, Cosmo/Aries Pharmaceuticals; stock/stock options: Virgo Inc. Consulting on behalf of Mayo Clinic: Boston Scientific. Microtek General payments/Minor Food and Beverage: Boston Scientif
Springer
2548860
Article
Q3
395
12596